National Clinical Research Centers

National Clinical Research (NCR) is a premier clinical research site network and contract research organization (CRO) headquartered in Richmond, Virginia. Founded in 1984, the company has established a long-standing reputation for conducting Phase I-IV clinical trials with a focus on high-quality data and rapid patient recruitment. NCR operates multiple specialized research centers, notably in Richmond and Savannah, covering therapeutic areas such as vaccines, central nervous system (CNS) disorders, women's health, and internal medicine. In December 2019, the company was acquired by CenExel Clinical Research, a major national network of clinical trial sites. Following the acquisition, NCR's facilities have been integrated into the CenExel platform, continuing to serve global pharmaceutical and biotechnology sponsors. The company is recognized for its expertise in complex trial protocols and its ability to consistently meet enrollment targets for large-scale clinical programs.